Antiangiogenic therapy and p53.

Timothy Browder; Judah Folkman; Philip Hahnfeldt; John Heymach; Lynn Hlatky; Mark Kieran; Michael S. Rogers

Antiangiogenic therapy and p53.

Timothy Browder, Judah Folkman, Philip Hahnfeldt, John Heymach, Lynn Hlatky, Mark Kieran, Michael S. Rogers

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	471; discussion 471
Journal	Science
Volume	297
Issue number	5581
State	Published - Jul 26 2002
Externally published	Yes

ASJC Scopus subject areas

General

Cite this

@article{ce74449705ee466d9977fc39205b522b,

title = "Antiangiogenic therapy and p53.",

author = "Timothy Browder and Judah Folkman and Philip Hahnfeldt and John Heymach and Lynn Hlatky and Mark Kieran and Rogers, {Michael S.}",

note = "Copyright: This record is sourced from MEDLINE{\textregistered}/PubMed{\textregistered}, a database of the U.S. National Library of Medicine",

year = "2002",

month = jul,

day = "26",

language = "English (US)",

volume = "297",

pages = "471; discussion 471",

journal = "Science",

issn = "0036-8075",

publisher = "American Association for the Advancement of Science",

number = "5581",

}

TY - JOUR

T1 - Antiangiogenic therapy and p53.

AU - Browder, Timothy

AU - Folkman, Judah

AU - Hahnfeldt, Philip

AU - Heymach, John

AU - Hlatky, Lynn

AU - Kieran, Mark

AU - Rogers, Michael S.

N1 - Copyright: This record is sourced from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

PY - 2002/7/26

Y1 - 2002/7/26

UR - http://www.scopus.com/inward/record.url?scp=0344288376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344288376&partnerID=8YFLogxK

M3 - Comment/debate

C2 - 12143876

AN - SCOPUS:0344288376

SN - 0036-8075

VL - 297

SP - 471; discussion 471

JO - Science

JF - Science

IS - 5581

ER -

Antiangiogenic therapy and p53.

ASJC Scopus subject areas

Other files and links

Cite this